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Purpose: Abdominal obesity is a fundamental factor underlying the development 
of metabolic syndrome. Because of radiation exposure and cost, computed 
tomography or dual-energy X-ray absorptiometry to evaluate abdominal adiposity 
are not appropriate in children. Authors evaluated whether ultrasound results could 
be an indicator of insulin resistance and nonalcoholic fatty liver disease (NAFLD).
Methods: We enrolled 73 subjects (aged 6–16 years) who were evaluated 
abdominal adiposity by ultrasound. Subcutaneous fat thickness was defined as the 
measurement from the skin-fat interface to the linea alba, and visceral fat thickness 
(VFT) was defined as the thickness from the linea alba to the aorta. Anthropometric 
and biochemical metabolic parameters were also collected and compared. The 
subjects who met 2 criteria, radiologic confirmed fatty liver and alanine aminotrans-
ferase >40, were diagnosed with NAFLD.
Results: There was a strong positive correlation between VFT and obesity. VFT was 
highly correlated with the homeostasis model assessment for insulin resistance 
score (r=0.403, P<0.001). The area under the curve for VFT as a predictor of NAFLD 
was 0.875 (95% confidence interval [CI], 0.787–0.964). VFT of 34.3 mm was found 
to be the discriminating cutoff for NAFLD (sensitivity, 84.6%; specificity, 71.2%, 
respectively).
Conclusion: Ultrasound could be useful in measuring VFT and assessing abdominal 
adiposity in children. Moreover, increased VFT might be an appropriate prognostic 
factor for insulin resistance and NAFLD.
Keywords: Intra-abdominal fat, Ultrasonography, Child, Abdominal obesity meta-
bolic syndrome, Fatty liver
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Introduction
In recent years, obesity has become a major public health and medical care problem. The 
rates of overweight and obese children and adolescents continue to increase rapidly, and the 
World Health Organization classifies obesity as a disease1). The prevalence of childhood obesity 
has also increased in Korea2). The prevalence of obesity in 10- to 14-year-old males in Seoul has 
increased 10 fold from 1.7% to 17.9% between 1999 and 2002. This is as high as the 14%–17% 
rate in the United States3,4).
Obesity is closely associated with insulin resistance, dyslipidemia, hypertension, 
cardiovascular disease, and fatty liver. Hemodynamic and metabolic changes are related 
and play important roles in the development of metabolic syndrome5). The amount of body 
fat itself is a risk factor; however, body fat distribution, particularly abdominal obesity, is a 
crucial risk factor for metabolic syndrome and cardiovascular disease6,7). Furthermore, the 
prevalence of nonalcoholic fatty liver disease (NAFLD), which is linked with high abdominal 
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fat, is increasing in children. Thus, identifying and measuring 
abdominal fat content are important for evaluating obesity in 
this vulnerable population.
Computed tomography (CT) and dual-energy X-ray absorp-
tiometry (DEXA) are commonly used methods to measure 
abdominal obesity in adults. However, the high cost and 
radiation exposure make them challenging to use in children 
and adolescents in clinical settings8,9). 
Since Armellini et al.10) first suggested the utility of ultrasound 
to measure abdominal fat in 1990, many studies have employed 
this method11). One study reported a high correlation for 
abdominal fat measurement between ultrasound and CT12). 
Although ultrasound might be a good method to replace CT in 
adults, there are few studies in pediatric populations.
In this study, we investigated the utility of ultrasound in 
measuring abdominal fat and the relationship of this value 
with obesity indicators. We also evaluated whether the results 
of ultrasound could be an indicator of insulin resistance and 
NAFLD.
Materials and methods
We retrospectively analyzed data from 73 subjects (aged 6–16 
years) who visited the Gangnam Severance Hospital, Yonsei 
University between January 2013 and December 2014, for 
obesity and growth assessment that included ultrasound and 
blood testing. We excluded patients who might have diseases 
that can interrupt normal growth. This study was approved by 
the Institutional Review Board of Yonsei University Gangnam 
Severance Hospital (approval number: 3-2015-0099).
We performed ultrasound evaluation to measure abdominal 
obesity, including visceral fat thickness (VFT) and subcutaneous 
fat thickness (SFT). Ultrasonography was performed with a 
high-resolution ultrasonographic system (SA 9900; Medison, 
Seoul, Korea). VFT was defined as the thickness of fat tissue 
between the linea alba and aorta, and SFT was defined as fat 
tissue thickness from the skin-fat interface to the linea alba. 
Transverse scanning was performed to measure the maximum 
SFT and VFT using 7.5- and 3.5-MHz probes, respectively. Both 
measures were obtained 1 cm above the umbilicus by the same 
pediatric radiologist.
 Anthropometric data, and biochemical measurements 
were collected by nurse. Participants underwent a standard 
examination and testing including measurement of height, 
weight, body mass index (BMI), lipid profiles, aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), 
protein, and albumin. The height and weight were measured to 
the nearest 0.1 cm and 0.1 kg, respectively, while the subjects 
were wearing light clothing and not wearing shoes. The waist 
circumference was measured at the midpoint between the lateral 
iliac crest and the lowest rib. The homeostasis model assessment 
for insulin resistance (HOMA-IR) score was used as an 
indicator of insulin resistance13). We defined standard deviation 
score for height, weight, and BMI based on the 2007 Korean 
National Growth Charts14). The subjects who met 2 criteria, 
radiologic confirmed fatty liver and ALT>40, were diagnosed 
with NAFLD. We divided the participants into 3 groups. BMI 
percentiles above the 95th percentile are labeled ‘overweight,’ 
BMI percentiles between the 85th and 95th percentiles are 
labeled ‘at risk for overweight,’ and BMI percentiles below the 
85th are ‘normal’15).
Statistical analyses were performed with SAS ver. 9.2 (SAS 
Institute, Cary, NC, USA). Associations between continuous 
variables were determined using Pearson correlation coefficients. 
Intergroup comparisons were performed with independent-
sample t-tests. Multiple regression tests were used to verify the 
association of VFT and insulin resistance. Analyses of variance 
and Fisher exact tests were used to compare the 3 groups. A 
receiver operating characteristic (ROC) curve was used to 
determine the appropriate VFT cutoff value. Differences were 
considered significant at P<0.05.
Results
We analyzed the baseline clinical and biochemical parameters, 
and Table 1 shows the mean and standard deviation values for 
the 47 males and 26 females enrolled in this study. The mean 
BMI z-score of the participants was 1.7, indicating that most 
Table 1. Anthropometric data (n=73)
Parameter Value
Age (yr) 10.3±2.3
Sex
  Male:female 47:26
Height z-score   1.1±1.1
Weight z-score   1.8±0.7
BMI z-score   1.7±0.6
Glucose (mg/dL)   98.1±13.5
AST (IU/L)   28.6±11.2
ALT (IU/L)   31.5±25.4
Cholesterol (mg/dL) 182.7±31.6
TG (mg/dL) 138.7±90.0
LDL (mg/dL) 102.6±20.3
HDL (mg/dL) 49.3±9.1
Insulin (μU/mL) 17.0±7.6
CRP (mg/L)   1.9±1.5
Abdomen circumference (cm) 88.2±9.4
VFT (mm)   32.6±10.6
SFT (mm) 20.1±7.6
VFT:SFT ratio   1.8±0.7
Fatty liver (n) 30
HOMA-IR   4.2±2.1
Values are presented as mean±standard deviation unless 
otherwise indicated.
BMI, body mass index; AST, aspartate aminotransferase; ALT, 
alanine aminotransferase; TG, triglycerides; LDL, low-density 
lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive 
protein; VFT, visceral fat thickness; SFT, subcutaneous fat 
thickness; HOMA-IR, homeostasis model assessment for insulin 
resistance.
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subjects were overweight or obese. 
The subjects were classified into 3 groups based on BMI 
percentile groups (Table 2). We identified the increasing trends 
of ALT, insulin, abdomen circumference, VFT, SFT, and HOMA-
IR in 3 groups. There were no significant differences in glucose 
and high-density lipoprotein (HDL) among the 3 groups. The 
number of fatty liver was 2 of 9 (22.2%) in BMI <85th percentile 
group, 7 of 27 (25.9%) in BMI 85th–95th percentile group, and 
21 of 37 (56.8%) in BMI >95th percentile group (P=0.024). We 
also observed a significant difference of HOMA-IR score, which 
represented insulin resistance (P=0.008).
Table 3 shows the Pearson correlation coefficients between 
VFT and biochemical factors. As well as BMI z-score, most 
biochemical data were highly correlated with VFT. The 
measures most highly correlated with VFT were ALT, insulin, 
and HOMA-IR. 
The variances of biochemical factors explaining HOMA-IR 
obtained with multiple regression analysis are shown in Table 4. 
Age (P=0.022), BMI z-score (P=0.024), abdomen circumference 
(P=0.016), VFT (P=0.048) were independent determinants of 
HOMA-IR (R2 of the model=0.278). 
The area under the ROC curve for VFT as a predictor of 
elevated ALT was 0.849 (95% confidence interval [CI], 0.735–
0.963). Relative to VFT 32.0 mm, the sensitivity and specificity to 
predict ALT >40 IU/L were 88.2% and 74.1%, respectively. ROC 
analysis of VFT to predict the presence of fatty liver yielded an 
area under the curve of 0.751 (95% CI, 0.643–0.859). Relative 
to VFT 31.8 mm, the sensitivity and specificity to diagnose 
radiologic fatty liver were 71.0% and 77.5%, respectively. The 
ROC for VFT as a predictor of NAFLD was 0.875 (95% CI, 
0.787–0.964). VFT 34.3 mm, the sensitivity and specificity to 
Table 2. Comparison of clinical characteristics among the three BMI percentile groups
Variable BMI <85th percentile(n=9)
BMI, 85th–95th percentile 
(n=27)
BMI >95th percentile
(n=37) P-value P for trend
Glucose (mg/dL)   101.1±13.1 95.8±5.9   99.1±17.2 0.495 0.684
AST (IU/L)   27.1±5.0 26.0±9.3   30.9±13.1 0.197 0.358
ALT (IU/L)     23.0±18.2   24.8±16.9   39.4±29.2 0.024* 0.011
Cholesterol (mg/dL)   184.9±16.0 184.7±31.7 180.7±34.8 0.861 0.725
TG (mg/dL)   106.0±44.0 130.7±73.7   152.5±106.4 0.326 0.168
HDL (mg/dL)     51.6±10.0 51.2±9.5 47.5±8.6 0.233 0.238
LDL (mg/dL) 100.3±7.8 103.4±23.0 103.0±24.7 0.842 0.971
Insulin (μU/mL)   13.0±5.4 14.5±6.2 19.9±8.0 0.004* 0.011
CRP (mg/L)      0.5±0.4   1.5±1.4   2.3±1.5 0.120 0.093
Abdomen circumference (cm)   78.5±4.8 86.7±7.7 95.4±9.1 0.003* 0.001
VFT (mm)     27.3±10.5 28.5±7.3   37.0±11.0 0.001* 0.009
SFT (mm)   14.4±5.5 17.8±5.9 23.0±7.9 0.009* 0.009
No. of fatty liver (%) 2 (22.2) 7 (25.9) 21 (56.8) 0.024† -
HOMA-IR     3.4±1.9   3.5±1.5   4.9±2.3 0.008* 0.037
Values are presented as mean±standard deviation unless otherwise indicated.
BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TG, triglycerides; LDL, low-density lipoprotein; HDL, 
high-density lipoprotein; CRP, C-reactive protein; VFT, visceral fat thickness; SFT, subcutaneous fat thickness; HOMA-IR, homeostasis model 
assessment for insulin resistance.
*Significantly different from analysis of variance test: P<0.05. †Significantly different from Fisher exact tests: P<0.05
Table 3. Pearson correlation coefficients of biochemical factors 
to VFT
Parameter
VFT
r P-value
Glucose (mg/dL) 0.055 0.644
BMI z-score 0.505 <0.001
AST (IU/L) 0.247 0.037
ALT (IU/L) 0.411 <0.001
Cholesterol (mg/dL) 0.098 0.415
TG (mg/dL) 0.272 0.021
HDL (mg/dL) -0.247 0.037
Insulin (μU/mL) 0.436 <0.001
CRP (mg/L) 0.212 0.236
Abdomen circumference (cm) 0.635 <0.001
SFT (mm) 0.325 0.021
HOMA-IR 0.403 <0.001
VFT, visceral fat thickness; BMI, body mass index; AST, aspartate 
aminotransferase; ALT, alanine aminotransferase; TG, triglycerides; LDL, 
low-density lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive 
protein; SFT, subcutaneous fat thickness; HOMA-IR, homeostasis model 
assessment for insulin resistance.
Table 4. Multiple regression analysis variances of biochemical 
factors explaining HOMA-IR 
Variable
HOMA-IR
Beta (β) SE (β) P-value
Age 0.896 0.855 0.022
ALT -0.002 -0.031 0.897
BMI z-score 3.549 0.889 0.024
Abdomen circumference -0.249 -1.123 0.016
VFT 0.054 0.271 0.048
HOMA-IR, homeostasis model assessment for insulin resistance; 
SE, standard error; ALT, alanine aminotransferase; BMI, body mass 
index; VFT, visceral fat thickness. 
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diagnose NAFLD were 84.6% and 71.2% (Fig. 1).
 
Discussion
Obesity is increasing at a rapid pace, and related complications 
are growing problems in both adults and children. BMI is 
widely used as a standard for determining whether subjects are 
overweight or obese16). However, BMI does not reflect body fat 
distribution. Especially in children, BMI does not adequately 
assess abdominal obesity because the amount of change in body 
fat varies depending on growth and development according to 
age17,18).
Fat distribution is a more important independent risk 
factor for cardiovascular disease than percent body fat in 
children and adolescents. A higher fat distribution in the 
abdomen is associated with increases in insulin resistance, 
hyperinsulinemia, and triglycerides (TG), decreased HDL 
cholesterol, high blood pressure, and the risk of cardiovascular 
disease19-21). Greater central fat deposition is also associated with 
less favorable plasma lipid and lipoprotein concentrations, high 
blood pressure, and greater left ventricular mass22,23). Therefore, 
we evaluated central obesity by measuring VFT with ultrasound 
and found strong positive correlations with liver enzyme and 
TG levels, and a negative correlation with HDL levels. These 
findings are consistent with previous studies24,25). As well as BMI, 
VFT had high correlations with metabolic biomarkers such as 
AST, TG, HDL, and serum insulin levels.
A high correlation between central obesity and insulin 
resistance has been reported26). Adipose tissue modulates 
metabolism by releasing nonesterified fatty acids, glycerol, 
hormones including leptin and adiponectin, and proinflamma-
tory cytokines27). The production of these products is increased 
in the setting of central obesity28). However, insulin resistance 
also frequently occurs in apparently lean individuals. In a 
previous study, visceral fat was more strongly correlated with 
insulin resistance than subcutaneous fat29). In this study, there 
was also a high correlation between VFT and HOMA-IR, which 
is an indicator of insulin resistance. Thus, among central obesity 
measurements, visceral fat accumulation is more useful than 
other markers.
The rise in the incidence of obesity in children is paralleled 
by higher rates of fatty liver. NAFLD has become one of the 
most common chronic hepatopathies in children. Its histologi-
cally proven prevalence in children in the United States 
ranges from 9.6% in normal-weight individuals up to 38% in 
obese subjects30). Nonalcoholic steatohepatitis (NASH) is a 
subtype of NAFLD accompanied by hepatocyte ballooning 
and necrosis with or without Mallory’s hyaline and fibrosis, 
and it is potentially progressive in pediatric subjects. Children 
with NASH may progress to liver cirrhosis and end-stage liver 
disease with a consequent need for liver transplantation31). Due 
to its tendency to progress during childhood or after transition 
into adulthood, early diagnosis and treatment are important. 
However, NASH is still underdiagnosed in children because the 
standard confirmatory test is liver biopsy, which has limitations 
in this population. Ultrasound is the most common imaging 
technique used for NAFLD screening, but it alone is not 
sufficient for diagnosis because radiological findings cannot 
distinguish between NASH and other forms of NAFLD32). We 
identified a significant relationship between VFT and altered 
lipid profile, elevated ALT, and insulin resistance. A VFT of 34.3 
mm was a cutoff value to support the diagnosis of NAFLD 
(sensitivity, 84.6%; specificity, 71.2%). Therefore, measuring 
VFT can be a useful technique to increase NAFLD diagnostic 
accuracy.
There are several limitations to our analysis. First, because it 
was a cross-sectional study, the results do not shed light on age-
related changes. Longitudinal analyses are needed to clarify 
this important issue. Second, our analysis was performed 
in Korean population, and the VFT cutoff values may differ 
among ethnic groups. Third, there is a lack of data showing a 
correlation between VFT and pathologically proven NASH, and 
comparisons with more established methods such as CT and 
DXEA. Fourth, by targeting a wide age group, it did not reflect 
the normal skin and fat thickness variation. Fifth, there was no 
comparison data about SFT. These issues should be considered 
when designing future clinical studies.
In conclusion, ultrasound could be useful for measuring 
abdominal fat thickness and assessing central obesity in 
children and adolescents. Moreover, ultrasound-measured VFT 
is an appropriate prognostic factor for ALT elevation, insulin 
resistance, and NAFLD. Although measuring VFT by ultrasound 
is not sufficient to determine if  a subject has metabolic 
syndrome or NASH, our results demonstrate that the addition 
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Fig. 1. Receiver operating characteristic (ROC) analysis of visceral fat thickness 
(VFT) as a predictor of nonalcoholic fatty liver disease (NAFLD). The ROC for VFT 
as a predictor of NAFLD was 0.875 (95% confidence interval, 0.787–0.964). VFT of 
34.3 mm was found to be the discriminating cutoff for NAFLD (sensitivity, 84.6%; 
specificity, 71.2%, respectively). ALT, alanine aminotransferase.
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of ultrasound-measured VFT significantly improved the 
prediction of metabolic changes or NAFLD. Ultrasonography 
is an inexpensive and noninvasive method compared to CT or 
DEXA. In the future, it can be a helpful adjunct for increasing 
the accuracy of diagnosing NAFLD and NASH. 
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